Abstract 4532: Preclinical evaluation of JTX-1811, an anti-CCR8 antibody with enhanced ADCC activity, for preferential depletion of tumor-infiltrating regulatory T cells
暂无分享，去创建一个
Changyun Hu | M. Gostissa | E. Stack | B. Klebanov | M. Willer | D. Shaffer | M. Meehl | A. Mora | Vikki Spaulding | Chang Xu | J. Weaver | Yan Zhang | B. Umiker | K. Meetze | Masie Wong | Seema Naheed | Anirudh Singh | M. Priess | L. McGrath | C. Fregeau | J. Buggé | Kristen Legendre | Dhruvkumar Upadhyay | F. Dépis